Literature DB >> 7631160

Systemic and secretory humoral immunity in the normal human vaginal tract.

H Hocini1, A Barra, L Bélec, S Iscaki, J L Preud'homme, J Pillot, J P Bouvet.   

Abstract

The molecular status of Abs in the vaginal fluid is reconsidered as a basis for immunization strategies for women' vaccination against HIV. Analysis of separated immunoglobulins (Igs) shows a large proportion of uncleaved IgG, whereas the low amount of IgA includes SIgA, monomers and fragments. SIgM is at a very low level, while free SC molecules are abundant. In addition to the already documented local synthesis, vaginal IgG contains serum-derived tetanus antitoxins. The IgG could reach the lumen by diffusion, and/or be transported by an Fc receptor-associated mechanism as suggested by the subclass imbalance in favour of the IgG1 isotype. VAginal SIgA contains very low levels of antibodies o the cell-well carbohydrates from a dental caries-associated streptococcus confirming the participation of the secretory immune system. IN addition, the low percentage of IgA2 suggests tha a proportion of vaginal SIgA can also derive from actively transported serum polymers. In agreement with our previous studies showing induction of vaginal tetanus antitoxins by intramuscular immunization, these results are in favour of classical, parenteral vaccinations to induce protection of the human vagina.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7631160     DOI: 10.1111/j.1365-3083.1995.tb03653.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  17 in total

1.  Evidence for a unique expression of CD4 on murine vaginal CD4+ cells.

Authors:  F L Wormley; M Scott; W Luo; M Baker; J Chaiban; P L Fidel
Journal:  Immunology       Date:  2000-07       Impact factor: 7.397

Review 2.  How can HIV-type-1-Env immunogenicity be improved to facilitate antibody-based vaccine development?

Authors:  Per Johan Klasse; Rogier W Sanders; Andrea Cerutti; John P Moore
Journal:  AIDS Res Hum Retroviruses       Date:  2011-05-20       Impact factor: 2.205

3.  Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women.

Authors:  P A Kozlowski; S Cu-Uvin; M R Neutra; T P Flanigan
Journal:  Infect Immun       Date:  1997-04       Impact factor: 3.441

4.  Roles of glycoproteins and oligosaccharides found in human vaginal fluid in bacterial adherence.

Authors:  N Rajan; Q Cao; B E Anderson; D L Pruden; J Sensibar; J L Duncan; A J Schaeffer
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

5.  Molecular characterization of the cervical and systemic B-cell repertoire: Unique, yet overlapping, immune compartments of an HIV-1 resistant individual.

Authors:  Ryan G Gaudet; Felix Breden; Frank Plummer; Jody D Berry
Journal:  MAbs       Date:  2011-03-01       Impact factor: 5.857

6.  Use of cellular depletion analysis to examine circulation of immune effector function between the vagina and the periphery.

Authors:  P L Fidel; W Luo; J Chabain; N A Wolf; E Van Buren
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

7.  Humoral immunogenicity of an HIV-1 envelope residue 649-684 membrane-proximal region peptide fused to the plague antigen F1-V.

Authors:  Nobuyuki Matoba; Namrata Rahul Shah; Tsafrir S Mor
Journal:  Vaccine       Date:  2011-07-13       Impact factor: 3.641

Review 8.  Immunopathogenesis of recurrent vulvovaginal candidiasis.

Authors:  P L Fidel; J D Sobel
Journal:  Clin Microbiol Rev       Date:  1996-07       Impact factor: 26.132

9.  Cervicovaginal neutralizing antibodies to herpes simplex virus (HSV) in women seropositive for HSV Types 1 and 2.

Authors:  Francois-Xavier Mbopi-Kéou; Laurent Bélec; Julie Dalessio; Jérôme Legoff; Gérard Grésenguet; Philippe Mayaud; David W G Brown; Rhoda Ashley Morrow
Journal:  Clin Diagn Lab Immunol       Date:  2003-05

10.  Infection of macrophages and dendritic cells with primary R5-tropic human immunodeficiency virus type 1 inhibited by natural polyreactive anti-CCR5 antibodies purified from cervicovaginal secretions.

Authors:  Jobin Eslahpazir; Mohammad-Ali Jenabian; Hicham Bouhlal; Hakim Hocini; Cédric Carbonneil; Gérard Grésenguet; François-Xavier Mbopi Kéou; Jérôme LeGoff; Héla Saïdi; Mary Requena; Nadine Nasreddine; Jean de Dieu Longo; Srinivas V Kaveri; Laurent Bélec
Journal:  Clin Vaccine Immunol       Date:  2008-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.